Collaborative grant, Call number HORIZON-HLTH-2027-02-DISEASE-14-TWO-STAGE
Clinical trials for advancing innovative interventions for neurodegenerative diseases
European Commission (Horizon Europe)
- , Add deadline: choose a calendar
- €10,000,000
- Early independent researcher · Mid-career researcher · Established researcher
- Institution applies
- Clinical Neurology, Neuropharmacology and
About
Two-stage Horizon Europe call for clinical trials of innovative therapeutic interventions for neurodegenerative diseases, combining an active substance with complementary approaches, sharing data under FAIR principles and engaging patients and caregivers.
Topics
- Clinical trials, search World Wide
- innovative therapeutic interventions, search World Wide
- neurodegenerative diseases, search World Wide
- active substance, search World Wide
- complementary approaches, search World Wide
- Horizon Europe, search World Wide
- FAIR principles, search World Wide
- patients, search World Wide
- caregivers, search World Wide
Eligibility
Covers: Estimated EU contribution of EUR 10 million per project; about four projects from a EUR 39.3 million topic budget.
Legal entities in EU Member States and Horizon Europe associated countries; other countries per Horizon Europe General Annex B.
Consortia meeting Horizon Europe eligibility; legal entities established in the United States are also eligible for Union funding. First-stage proposals are evaluated blind; invited second-stage proposals are due 16 September 2027.
Source: ec.europa.eu